Jefferies Financial Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-55,400
Closed -$4.91M 1676
2022
Q4
$4.91M Buy
+55,400
New +$4.6M 0.03% 409

Other funds holding CNMD

Jefferies Financial Group's CNMD Position: Q1 2026 in Review

Jefferies Financial Group increased its CONMED (CNMD) stake by 404% in Q1 2026, buying an estimated $821K and bringing the position to 25,177 shares worth $890K. The position accounts for 0.01% of the portfolio, ranked #974.

Jefferies Financial Group first reported a position in CNMD in Q4 2022 and has held it in 11 quarters since. The position peaked at $14.7M in Q4 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Jefferies Financial Group held 25,177 shares of CONMED worth $890K as of Q1 2026.
  • Jefferies Financial Group bought 20,179 CONMED shares in Q1 2026, an estimated $821K.
  • CONMED made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #974 holding.
  • Jefferies Financial Group first reported a position in CONMED in Q4 2022 and has held it in 11 quarters since.
  • Jefferies Financial Group's CONMED position peaked at $14.7M in Q4 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.